Sofinov Societe Financiere D'Innovation
10
27M
10
7
- Areas of investment
Summary
The company was established in North America in Canada. The leading representative office of defined Corporate Investor is situated in the Montru00e9al.
Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most popular fund investment industries, there are Internet, Therapeutics. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight 800.COM, Therion Biologics, Tandem Medical, Inc. The fund has specific favorite in a number of founders of portfolio startups.
The increased amount of exits for fund were in 2019. Deals in the range of 10 - 50 millions dollars are the general things for fund. Comparing to the other companies, this Sofinov Societe Financiere D'Innovation performs on 28 percentage points more the average number of lead investments. The fund is constantly included in less than 2 deals per year. The top activity for fund was in 2000.
The usual cause for the fund is to invest in rounds with 4-5 partakers. The meaningful sponsors for the fund in investment in the same round are Woodside Fund, United Offshore Bank Venture Technology Investments, Trinity Ventures. In the next rounds fund is usually obtained by Woodside Fund, Sherbrooke Capital, POSCO BioVentures.
Investments analytics
Analytics
- Total investments
- 10
- Lead investments
- 0
- Exits
- 7
- Investments by industry
- Medical (6)
- Health Care (5)
- Biotechnology (5)
- Medical Device (2)
- Telecommunications (1) Show 13 more
- Investments by region
-
- United States (9)
- Canada (1)
- Peak activity year
- 2000
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 26
- Avg. valuation at time of investment
- 30M
- Group Appearance index
- 1.00
- Avg. company exit year
- 13
- Avg. multiplicator
- 1.25
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| CytoLogix | 29 Jan 2001 | Health Care, Medical Device, Medical | Early Stage Venture | 27M | United States, Massachusetts, Cambridge |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.